[Sucroferric oxyhydroxide (hyperphosphataemia in children and adolescents 2 years of age and older with CKD stages 4-5 or with CKD on dialysis) - Benefit assessment according to §35a Social Code Book V]
Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen
Record ID 32018003835
German
Original Title:
Sucroferric Oxyhydroxide (Serumphosphatkontrolle bei Kindern und Jugendlichen mit CKD)
Details
Project Status:
Completed
URL for project:
https://www.iqwig.de/projekte/a20-120.html
Year Published:
2021
URL for published report:
https://www.iqwig.de/download/a20-120_sucroferric-oxyhydroxide_nutzenbewertung-35a-sgb-v_v1-0.pdf
English language abstract:
There is no English language summary available
Publication Type:
Full HTA
Country:
Germany
MeSH Terms
- Kidney Failure, Chronic
- Child
- Hyperphosphatemia
- Dialysis
- Adolescent
- Ferric Compounds
- Sucrose
Keywords
- Sucroferric Oxyhydroxide
- Kidney Failure - Chronic
- Child
- Adolescent
- Benefit Assessment
- NCT02688764
Contact
Organisation Name:
Institute for Quality and Efficiency in Health Care (IQWiG)
Contact Address:
IQWiG, Im Mediapark, 8, DE-50670 Cologne, GERMANY, Tel: +49(0)221-35685, Fax: +49(0)221-356851
Contact Email:
berichte@iqwig.de
Copyright:
Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.